These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 339986)

  • 21. Treatment of stage D hormone-resistant carcinoma of the prostate with estramustine phosphate.
    Benson RC; Wear JB; Gill GM
    J Urol; 1979 Apr; 121(4):452-4. PubMed ID: 439216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Estracyt treatment in prostatic neoplasms].
    Sander S
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):27-8. PubMed ID: 1257949
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate.
    Mittelman A; Shukla SK; Welvaart K; Murphy GP
    Cancer Chemother Rep; 1975; 59(1):219-23. PubMed ID: 1093669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended therapy of stage D carcinoma of the prostate with oral estramustine phosphate.
    Mittelman A; Shukla SK; Murphy GP
    J Urol; 1976 Apr; 115(4):409-12. PubMed ID: 1263317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral estramustine phosphate (Estracyt): a broad phase II study.
    Halpern J; Catane R
    J Med; 1984; 15(1):35-43. PubMed ID: 6593404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
    Smith PH; Robinson M; Richards B; Suciu S; De Pauw M; Sylvester R; Denis L
    Urology; 1984 Jun; 23(6 Suppl):64-8. PubMed ID: 6375083
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC
    Wis Med J; 1976 Sep; 75(9):S89-90. PubMed ID: 969557
    [No Abstract]   [Full Text] [Related]  

  • 29. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
    Benson RC
    Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
    [No Abstract]   [Full Text] [Related]  

  • 30. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
    Andersson L; Berlin T; Boman J; Collste L; Edsmyr F; Esposti PL; Gustafsson H; Hedlund PO; Hultgren L; Leander G; Nordle O; Norlén H; Tillegård P
    Scand J Urol Nephrol Suppl; 1980; 55():143-5. PubMed ID: 6259722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F; Esposti PL; Andersson L
    Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of estramustine phosphate in the treatment of estrogen-resistant prostatic adenocarcinoma].
    Toulouse J; Jung JL; Bittard M
    J Urol (Paris); 1984; 90(1):27-33. PubMed ID: 6725973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L; Edsmyr F; Jönsson G; Könyves I
    Recent Results Cancer Res; 1977; (60):73-7. PubMed ID: 866798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by roswell park memorial institute.
    Murphy GP; Slack NH; Mittelman A
    Urology; 1984 Jun; 23(6 Suppl):54-63. PubMed ID: 6375081
    [No Abstract]   [Full Text] [Related]  

  • 35. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
    Mittelman A; Catane R; Murphy GP
    Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of estramustine phosphate on prostatic cancer estimated by transrectal ultrasonotomography.
    Watanabe H; Ohe H; Ando K; Sawamura Y; Niijima T; Nakamura S; Orikasa S; Tanahashi Y; Imamura K; Yoshida H
    Prostate; 1981; 2(2):155-61. PubMed ID: 7301654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary treatment of prostatic carcinoma with estramustine phosphate: preliminary report.
    Nilsson T; Jonsson G
    J Urol; 1976 Feb; 115(2):168-9. PubMed ID: 1249870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A; Lunglmayr G
    Wien Med Wochenschr; 1983; 133(7):179-81. PubMed ID: 6868629
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A; Morvay J; Vécsei B
    Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
    Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
    J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.